COVID-19
Rethinking Pharma’s Responsibilities in a Time of Crisis
Tim Tyson
TriRx Pharmaceutical Services
PAP-Q2-20-CL-001Jul 01, 2020
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
Nigel Walker
Nice Insight
PAP-Q2-20-NI-001Jul 01, 2020
Industry Leader Insight
Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site
Magnus Schroeder, Ph.D.
Avid Bioservices
PAP-Q2-20-CL-002Jul 01, 2020
Chronokines
Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers
Emilie Branch; Frank D. Lee
Pharma's Almanac
PAP-Q2-20-CL-003Jul 01, 2020
Secure Validated Shipping
The Essentiality of Transportation to the Pharma Industry
Andrew Boyle
Boyle Transportation
PAP-Q2-20-CL-004Jul 01, 2020
Fill-Finish Services
Avara Liscate: High Standards and Expertise in Sterile Manufacturing
Andrea Baiocchi
Avara Pharmaceutical Services
PAP-Q2-20-CL-005Jul 01, 2020
CDMO
Positioning a CDMO to Meet Future Needs
Tyler Kerr; James Balog; Andrew Waaso
Albemarle Fine Chemistry Services
PAP-Q2-20-CL-006Jul 01, 2020
Equipment
Common Challenges and Solutions of Equipment Ownership and Use
Matt Hicks
Federal Equipment Company
PAP-Q2-20-CL-007Jul 01, 2020
Microbiome
Selecting a Microbiome CDMO Partner for the Long Term
Dave Stevens; Jason Rahal
Arranta Bio
PAP-Q2-20-CL-008Jul 01, 2020
Integration
Creating Value through Best Practices Across a Global, Integrated Service Provider
Jeffrey Butler, Ph.D.
AMPAC Fine Chemicals
PAP-Q2-20-CL-009Jul 01, 2020
Research Innovation
Leveraging Innovative Technologies to Access Better Data More Efficiently and Cost-Effectively
Lorraine Rusch, Ph.D.; J. Fred Pritchard, Ph.D.
Celerion
PAP-Q2-20-CL-010Jul 01, 2020
Molecules
Molecules that Changed Medicine
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-002Jul 01, 2020
Aseptic Manufacturing
Aseptic Manufacturing with State-of-the-Art Technologies
Kurt R. Nielsen, Ph.D.
Pii
PAP-Q2-20-CL-011Jul 01, 2020
Antibody–Drug Conjugates
Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life
Loretta Itri, M.D., F.A.C.P.,; Usama Malik
Immunomedics
PAP-Q2-20-CL-012Jul 01, 2020
Chronokines
Solving Unmet Clinical Needs by Harnessing the Science of Aging
Emilie Branch; Elizabeth Jeffords
Pharma's Almanac
PAP-Q2-20-CL-013Jul 01, 2020
Cancer Therapies
Computational Discoveries for Clinical Development of Novel Cancer Therapies
David Alvaro, Ph.D.; Anat Cohen-Dayag, Ph.D.
Pharma's Almanac
PAP-Q2-20-CL-014Jul 01, 2020
Biosynthesis
Redesigning Organisms as Metabolism Architects
Cyrille Pauthenier, Ph.D.; Filippo Giancarlo Martinelli, PDEng
Abolis
PAP-Q2-20-CL-015Jul 01, 2020
Drug Repositioning
A Therapeutic Strategy for Neurological Disorders
Franck Mouthon; Mathieu Charvériat, Ph.D.
Theranexus
PAP-Q2-20-CL-016Jul 01, 2020
Immunotherapy
Leveraging the Native Immune Response to Fight Cancer
Asher Nathan
NeoTX
PAP-Q2-20-CL-017Jul 01, 2020
Immunotherapy
Applying the Principles of Immunotherapy to Infectious Diseases
Jeffrey Stein, Ph.D.
Cidara Therapeutics
PAP-Q2-20-CL-018Jul 01, 2020